(Q34512130)

2 August 2017

Intrathecal baclofen for dystonia: benefits and complications during six years of experience (English)

1 reference

2 August 2017

Walker RH

1

1 reference

2 August 2017

Danisi FO

2

1 reference

2 August 2017

Swope DM

3

1 reference

2 August 2017

Goodman RR

4

1 reference

2 August 2017

Germano IM

5

1 reference

2 August 2017

Brin MF

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

2 August 2017

1 reference

2 August 2017

15

1 reference

2 August 2017

6

1 reference

2 August 2017

1242-1247

1 reference

Intrathecal baclofen alleviates spinal cord spasticity

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Chronic intrathecal baclofen administration for control of severe spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Continuous intrathecal baclofen infusion for spasticity of cerebral origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Baclofen in the treatment of cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Intrathecal baclofen in cerebral palsy movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Severe tardive dystonia: treatment with continuous intrathecal baclofen administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Intrathecal baclofen for intractable axial dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Risk factors for suicide in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Suicide and patients with neurologic diseases. Methodologic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Suicide and multiple sclerosis: an epidemiological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1242%3A%3AAID-MDS1028%3E3.0.CO%3B2-Z

10.1002/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference